بوابة الشروق
بوابة الشروق
Ready to play
Ready to play
The Egyptian Drug Authority has approved the re-pricing of approximately 40 pharmaceutical products and the increase in their prices, starting from January 2024, following the submission of around 400 requests by companies since July. Price increases will be implemented gradually on certain items, while market surveillance will continue to prevent drug withdrawals or monopolies. It is worth noting that the Egyptian market includes about 17,000 drug products, more than 90% of which are locally manufactured. Sales are expected to continue rising, reaching 240 billion Egyptian pounds by the end of the year, with the goal of increasing local manufacturing to 95% by 2035.
Notice: This Is an AI-Generated Summary
Comments (0)